1. Home
  2. HLIO vs NEO Comparison

HLIO vs NEO Comparison

Compare HLIO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HLIO

Helios Technologies Inc.

SELL

Current Price

$68.51

Market Cap

2.3B

Sector

Industrials

ML Signal

SELL

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

SELL

Current Price

$16.72

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HLIO
NEO
Founded
1970
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Precision Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.1B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
HLIO
NEO
Price
$68.51
$16.72
Analyst Decision
Strong Buy
Buy
Analyst Count
6
12
Target Price
★ $94.67
$21.55
AVG Volume (30 Days)
350.8K
★ 2.3M
Earning Date
11-02-2026
10-27-2026
Dividend Yield
★ 0.70%
N/A
EPS Growth
★ 23.93
N/A
EPS
★ 1.25
N/A
Revenue
★ $200,727,000.00
N/A
Revenue This Year
$6.91
$10.67
Revenue Next Year
$5.86
$9.96
P/E Ratio
$55.10
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.00
$7.07
52 Week High
$95.05
$20.15

Technical Indicators

Market Signals
Indicator
HLIO
NEO
Relative Strength Index (RSI) 44.45 44.33
Support Level $66.25 $15.72
Resistance Level $69.41 $16.92
Average True Range (ATR) 1.78 0.98
MACD 0.25 -0.34
Stochastic Oscillator 27.77 29.01

Price Performance

Historical Comparison
HLIO
NEO

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: